107 related articles for article (PubMed ID: 10780214)
21. [The role of MIBI scintigraphy in the early detection of breast cancer].
Tanyi M; Fülöp B; Garami Z; Garai I; Tanyi J; Lukács G
Magy Seb; 2001 Apr; 54(2):118-22. PubMed ID: 11339088
[TBL] [Abstract][Full Text] [Related]
22. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
23. [Breast scintigraphy with technetium 99m sestamibi, as support to radiologic methods in the study of breast lesions].
Occhiato R; Schillaci O; Broglia L; Danieli R; Narilli P; Pavone P; Scopinaro F; Passariello R
Radiol Med; 1996 May; 91(5):581-4. PubMed ID: 8693123
[TBL] [Abstract][Full Text] [Related]
24. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
25. [New criteria for scintigraphic follow-up of bone metastases following radiotherapy. Results of functional scintigraphy using 99mTc-MDP].
Knop J; Stritzke P; Langendorff G
Nuklearmedizin; 1985 Dec; 24(5-6):238-43. PubMed ID: 4094901
[TBL] [Abstract][Full Text] [Related]
26. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
27. An Unusual Presentation of Breast Implant Rupture.
Hudson A; Brown RKJ; Minoshima S; Dunn D
Clin Nucl Med; 2022 Mar; 47(3):e271-e273. PubMed ID: 35025807
[TBL] [Abstract][Full Text] [Related]
28. Bone scintigraphy in the monitoring of treatment effect of bisphosphonates in bone metastatic breast cancer.
Chavdarova L; Piperkova E; Tsonevska A; Timcheva K; Dimitrova M
J BUON; 2006; 11(4):499-504. PubMed ID: 17309184
[TBL] [Abstract][Full Text] [Related]
29. Technetium-99m-MDP patterns in patients with painful shoulder lesions.
Clunie G; Bomanji J; Ell PJ
J Nucl Med; 1997 Sep; 38(9):1491-5. PubMed ID: 9293816
[TBL] [Abstract][Full Text] [Related]
30. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
31. [The value of 99mTc-MIBI image axillary lymph node in selecting operative method for breast cancer].
Qu X; Wang Y; Chen D; Li C
Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):41-3. PubMed ID: 11829776
[TBL] [Abstract][Full Text] [Related]
32. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
[TBL] [Abstract][Full Text] [Related]
33. Detection of osteomyelitis at fracture nonunion sites: comparison of two scintigraphic methods.
Seabold JE; Nepola JV; Conrad GR; Marsh JL; Montgomery WJ; Bricker JA; Kirchner PT
AJR Am J Roentgenol; 1989 May; 152(5):1021-7. PubMed ID: 2705339
[TBL] [Abstract][Full Text] [Related]
34. Ischemic Muscle Necrosis of Lower Extremities in Peripheral Arterial Disease: The Impact of 99mTc-MDP Scintigraphy on Patient Management.
Jocius D; Vajauskas D; Skrebunas A; Gutauskas M; Tamosiunas AE
Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31795274
[No Abstract] [Full Text] [Related]
35. [Abnormal accumulation of 99mTc-MDP in cancer of the breast].
Katoh S; Sugiyama S; Yamakawa M; Okazaki A; Miyaishi K; Niibe H; Itoh J; Suto H
Rinsho Hoshasen; 1986 Aug; 31(8):881-4. PubMed ID: 3773282
[No Abstract] [Full Text] [Related]
36. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
Coleman RE; Meier CA; Rubens RD; Fogelman I
Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
[TBL] [Abstract][Full Text] [Related]
37. Primary osteogenic sarcoma of the breast demonstrated by Tc-99m MDP scintigraphy.
Lee JK; Sun SS
Clin Nucl Med; 1998 Sep; 23(9):619. PubMed ID: 9735989
[No Abstract] [Full Text] [Related]
38. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
[TBL] [Abstract][Full Text] [Related]
39. Scintimammography with 99mTc-MDP: experience of the National Cancer Institute of Naples.
Piccolo S; Lastoria S; Thomas R; Muto P; Apicella A; Petrosino T; Cortino G; D'Aiuto G; Ziviello M
Eur J Radiol; 1998 May; 27 Suppl 2():S275-81. PubMed ID: 9652535
[TBL] [Abstract][Full Text] [Related]
40. The evaluation of combined scintimammography and tumor markers in breast cancer patients.
Mangkharak J; Patanachak C; Podhisuwan K; Pleehachinda R
Anticancer Res; 1997; 17(3B):1611-4. PubMed ID: 9179203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
